M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
GSK launches USD1m lupus initiative to improve diagnosis and care
Biopharmaceutical company GSK plc (LSE/NYSE: GSK) announced on Monday that it has Introduces the Linked by Lupus: Optimal Care Initiative, a new US-focused programme offering up to USD1m in grant funding to support national, state, and local non-profit and community-based organisations...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search